Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III
about
Identification of human autoantibodies to transcription factor IIBThe clinical relevance of autoantibodies in sclerodermaDynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity.Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human seraRepeat expansion affects both transcription initiation and elongation in friedreich ataxia cellsAtypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.Antibodies to the DNA-directed RNA polymerase II subunit RPB1 occur with highest frequency in centenariansCoexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit.Molecular structure and function of autoantigens in systemic sclerosis.Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesisOver-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.Autoimmunity to RNA polymerase II is focused at the carboxyl terminal domain of the large subunit.
P2860
Q24626133-1BC931BB-7D34-45BE-91CC-6BDF9743B9E9Q24682842-A3A3645F-07E4-40FE-B337-FF28BEA4423FQ33842100-95CD3358-02C2-47BF-B9C4-40FE734D8D0BQ34157808-AA4E8AB9-534F-4D31-8284-B17D8C47251BQ34575655-62A66A33-EAA0-4EAF-8697-A0BF37104BAAQ35617650-6378394D-C275-4B66-B1DC-98CF23FA1D5AQ35967168-88066212-A2E4-4158-A65C-EE1955E6CBAFQ36717766-60E80FFB-A374-458C-886D-66C25A1EC6F1Q37292117-A24105E1-F2C9-46DB-9DE5-DFA63B4B7F8AQ37353084-1808B1AA-FE0C-42C9-B558-D24C9882AE69Q40468515-45319556-CF5E-4B82-9E7B-D4534192AA74Q41968463-C1CF6608-4A9E-4F37-BBF3-881F3C113A2DQ47594222-ADD1B628-7F07-4631-AD4C-B7ADA07BD2A1Q55241437-BBDABF4C-74B3-415E-8274-986861A2F563
P2860
Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Identification of autoantibodi ...... s to RNA polymerases I and III
@ast
Identification of autoantibodi ...... s to RNA polymerases I and III
@en
type
label
Identification of autoantibodi ...... s to RNA polymerases I and III
@ast
Identification of autoantibodi ...... s to RNA polymerases I and III
@en
prefLabel
Identification of autoantibodi ...... s to RNA polymerases I and III
@ast
Identification of autoantibodi ...... s to RNA polymerases I and III
@en
P2093
P2860
P356
P1476
Identification of autoantibodi ...... s to RNA polymerases I and III
@en
P2093
J A Hardin
M Hirakata
T A Medsger
P2860
P304
P356
10.1172/JCI116505
P407
P577
1993-06-01T00:00:00Z